{
    "id": 9513,
    "name": "plasma cell leukemia",
    "source": "DOID",
    "definition": "A plasma cell neoplasm that is characterized by the presence of a circulating clonal plasma cell count that exceeds 2x10^9/L or is 20% of the leukocyte differential count. [url:https\\://en.wikipedia.org/wiki/Plasma_cell_leukemia, url:https\\://rarediseases.info.nih.gov/diseases/9373/index, url:https\\://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349791/]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:9513",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT03441958",
            "title": "ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma",
            "phase": "Phase Ib/II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 9468,
                    "therapyName": "Cyclophosphamide + ECT-001 cord blood cells + Fludarabine + Mycophenolate mofetil + Tacrolimus",
                    "synonyms": null
                }
            ]
        }
    ]
}